Skip to main content
. 2021 Aug 26;57(9):879. doi: 10.3390/medicina57090879

Figure 3.

Figure 3

Induction of apoptosis by luteolin A172 and U-373MG cells. (A) Luteolin (200 μM) activates cleaved caspase-3 in both GBM cells, as confirmed by immunocytochemistry using confocal microscopy. (B) Luteolin (0–200 μM) treatment activated caspase-3 and caspase-7 and cleaved PARP. The protein expression levels were detected by Western blot assay. β-actin was used as internal control. (C) Apoptotic cell populations detect by Annexin V/PI staining in luteolin-treated GBM cells.